ARCHIVES

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

Texas Cancer Plan Features Big Hike in Cigarette Tax

September 19, 1986

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

UICC Receives 1300 Abstracts For Congress In Oslo, Norway.

February 22, 2002

NCI Gets Concept Approval for New Communications Network

May 27, 1988

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008